Summary
Definition
History and exam
Key diagnostic factors
- presence of risk factors
- unknown toxin ingestion or exposure
- confusion, disorientation, agitation
- nausea, vomiting, epigastric pain
- fever, sweating, warm extremities, bounding pulses
- dyspnoea
- tachypnoea, hyperventilation, Kussmaul's respirations
- tinnitus and/or deafness
- malaise and/or dizziness
- movement disorders, asterixis, stupor
- confusion and/or delirium (irritability, hallucinations, deterioration in activities of daily living)
- coma and/or papilloedema
- convulsions
- rales plus low oxygen saturation (signs of heart failure)
Other diagnostic factors
- volume depletion/dehydration
- skin rash
- ventricular arrhythmias and asystole
- haematemesis
- disseminated intravascular coagulation
Risk factors
- ingestion of ≥125 mg/kg salicylate
- ingestion of oil of wintergreen (methyl salicylate)
- ingestion of bismuth subsalicylate
- history of self-harm or suicide attempt
- children aged ≤3 years and adults aged ≥70 years
Diagnostic investigations
1st investigations to order
- plasma salicylate concentration
- ABG
- serum electrolyte panel, urea and creatinine
- serum prothrombin time (PT), activated PTT, INR
- FBC
- capillary blood glucose
- ECG
Treatment algorithm
Contributors
Expert advisers
Marianne Gillings, BPharm(Hons), MBBS, MRCP(UK), PGDip(MedTox), FRCEM
Emergency Medicine Consultant
Gloucestershire Hospitals
UK
Disclosures
MG is a member of the RCEM Toxicology steering group (voluntary post). MG is co-author of the RCEM Best practice guideline Suspected Cannabinoid Hyperemesis Syndrome in the Emergency Department (November 2022). MG is co-author of the RCEM guidelines Suspected Nitrous Oxide Toxicity in Emergency Departments (April 2023). MG is a member of the Trial Steering Committee for the HiSNAP trial (voluntary).
Acknowledgements
BMJ Best Practice would like to gratefully acknowledge the previous team of expert contributors, whose work is retained in parts of the content:
Johann Grundlingh, MBChB, FCEM, FFICM, EDICM, DFMS, DipMedTox, MMedTox, MSB, ERT, MEWI, MBA
Emergency Medicine Consultant
Royal London Hospital
Barts Health NHS Trust
Honorary Senior Lecturer
Queen Mary University
London
UK
JG declares that he has no competing interests.
James Kelly, MA (Oxon), MPhil, MA, MBBS, PGDME
Education Academy Fellow in Critical Care
Newham University Hospital
London
UK
JK declares that he has no competing interests.
Chris Hoyte, MD
Medical Toxicology Fellowship Program Director
Rocky Mountain Poison and Drug Safety
Denver
Associate Professor
Department of Emergency Medicine
University of Colorado School of Medicine
Aurora
CO
CH declares that he has no competing interests.
Eric Lavonas, MD, MS
Attending Physician
Department of Emergency Medicine and Rocky Mountain Poison and Drug Safety
Denver Health
Denver
Professor
Department of Emergency Medicine
University of Colorado School of Medicine
Aurora
CO
Peer reviewers
Andreas Crede, MBChB, FCEM, MMed Emergency Medicine, PgDip Toxicology
Consultant
Emergency Department
Sheffield Teaching Hospitals NHS Foundation Trust
Sheffield
UK
Disclosures
AC declares that he has no competing interests.
Use of this content is subject to our disclaimer